ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

swedish orphan biovitrum international ab - nitisinone - tyrosinemias - drugi gastrointestinalni trakt i metabolizam, lijekovi, - hereditary tyrosinemia type 1 (ht 1)orfadin is indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht 1) in combination with dietary restriction of tyrosine and phenylalanine. alkaptonuria (aku)orfadin is indicated for the treatment of adult patients with alkaptonuria (aku).

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - telmisartan - hipertenzija - kardiovaskularni sustav - liječenje эссенциальной hipertenzije u odraslih:dodati na therapyonduarp navodi u odraslih osoba, čiji je krvni pritisak adekvatno ne prati амлодипином. zamjena therapyadult pacijentima, prima телмисартан i amlodipin od pojedinih tableta mogu se pojaviti tablete onduarp sadrže iste doze komponente .

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - pramipeksol dihidroklorid monohidrat - restless legs syndrome; parkinson disease - antiparkinsonski lijekovi - sifrol je indiciran za liječenje znakova i simptoma idiopatske parkinsonove bolesti, samostalno (bez levodope) ili u kombinaciji s levodopom, i. tijekom bolesti, ipak u kasnoj fazi kada učinak levodope jenjava ili postane nestalan i fluktuacije terapijski učinak pojaviti (kraj doze ili 'on-off' fluktuacije). sifrol indiciran za simptomatsko liječenje umjerene do teške idiopatskom sindrom nemirnih nogu u dozama do 0. 54 mg (0. 75 mg soli).

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

nordic group b.v. - тегафур, gimeracil, oteracil - neoplazme želuca - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

gilead sciences international ltd - elvitegravir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - vitekta primjenjuje istodobno s inhibitor proteaza i drugi antiretrovirusni lijekovi, je indiciran za liječenje ljudski immunodeficiency virus 1 (hiv-1) infekcije u odraslih koji su zaraženi sa hiv-1 bez poznate mutacije povezanih s rezistencijom na elvitegravir.

ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - imunosupresivi - molimo pogledajte odjeljak 4. 1 sažetak značajki proizvoda u dokumentu o informacijama o proizvodu.

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

allergan pharmaceuticals international limited, clonshaugh business and technology park, dublin , irska - deoksikolatna kiselina - otopina za injekciju - 10 mg/ml - urbroj: 1 ml otopine za injekciju sadrži 10 mg deoksikolatne kiseline

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

servier pharma d.o.o., ulica grge tuškana 37, zagreb, hrvatska - mikronizirana, pročišćena smjesa flavonoida koja se sastoji od 90% diosmina i 10% flavonoida izraženih kao hesperidin - filmom obložena tableta - 450 mg + 50 mg - urbroj: jedna filmom obložena tableta sadrži 500 mg pročišćene mikronizirane smjese flavonoida koja se sastoji od 450 mg diosmina (90 %) i 50 mg flavonoida izraženih kao hesperidin (10 %)

ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

galderma international, tour europlaza, 20 avenue andre prothin, la defense 4, la defense cedex, francuska - adapalen benzoilperoksid - gel - 1 mg/g + 25 mg/g - urbroj: 1 g gela sadrži 1 mg adapalena i 25 mg benzoilperoksida